Literature DB >> 2285499

Recent developments in the toxicology of anabolic steroids.

S Graham1, M Kennedy.   

Abstract

Anabolic steroids are extensively abused as ergogenic aids by athletes (and others). A number of features of anabolic steroid use and toxicology have been recently reviewed in the Journal, and a large body of data has accumulated concerning their toxic nature. The lipoprotein profile induced by anabolic steroids carries a markedly adverse cardiovascular risk. Glucose metabolism is significantly altered and includes peripheral insulin resistance, hyperinsulinaemia and attenuated responses to glucagon. Hypertension has been noted. Psychiatric and psychological alterations are major toxicities of anabolic steroids, and probably constitute the major mechanism of their action. Hepatic neoplasia occurs in the setting of abuse of this class of drugs, and may be related to their use, although there is no convincing evidence that other malignancies are induced in athletes who abuse them. Gross disturbance of reproductive function occurs in both sexes: hypogonadal states are common and prolonged. The anabolic steroids are toxic drugs with both long and short term effects. Their abuse by athletes is to be decried, particularly in view of the frequent and prolonged use by the young.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285499     DOI: 10.2165/00002018-199005060-00007

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  263 in total

1.  Mode of action and use of anabolic steroids.

Authors:  H R Gribbin; S G Matts
Journal:  Br J Clin Pract       Date:  1976-01

2.  The association of oral androgenic-anabolic steroids and life-threatening disease.

Authors:  F L Johnson
Journal:  Med Sci Sports       Date:  1975

3.  Peliosis hepatis; report of case.

Authors:  R A BURGER; P M MARCUSE
Journal:  Am J Clin Pathol       Date:  1952-06       Impact factor: 2.493

4.  Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.

Authors:  P D Thompson; E M Cullinane; S P Sady; C Chenevert; A L Saritelli; M A Sady; P N Herbert
Journal:  JAMA       Date:  1989-02-24       Impact factor: 56.272

5.  Anabolic androgenic steroids and suicide.

Authors:  K J Brower; F C Blow; G A Eliopulos; T P Beresford
Journal:  Am J Psychiatry       Date:  1989-08       Impact factor: 18.112

6.  Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines.

Authors:  P J Salt
Journal:  Eur J Pharmacol       Date:  1972-12       Impact factor: 4.432

7.  Deca-Durabolin and cytotoxic drugs.

Authors:  R Turner
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1985

8.  The effect of anabolic steroids on lean body mass: the dose response curve.

Authors:  G B Forbes
Journal:  Metabolism       Date:  1985-06       Impact factor: 8.694

9.  Metabolic effects of anabolic steroid on skeletal muscle.

Authors:  V Rogozkin
Journal:  Med Sci Sports       Date:  1979

10.  Response of serum hormones to androgen administration in power athletes.

Authors:  M Alén; M Reinilä; R Vihko
Journal:  Med Sci Sports Exerc       Date:  1985-06       Impact factor: 5.411

View more
  3 in total

1.  Drug doping in senior Australian rules football: a survey for frequency.

Authors:  K J Hardy; J J McNeil; A G Capes
Journal:  Br J Sports Med       Date:  1997-06       Impact factor: 13.800

Review 2.  Pharmacology of anabolic steroids.

Authors:  A T Kicman
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

Review 3.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.